참고문헌
- Fatkenheuer G, Taelman H, Lepage P, Schwenk A, Wenzel R. The return of tuberculosis. Diagn Microbiol Infect Dis 1999;34:136-46
-
Ministry of Health and Welfare, Korean Academy of Tuberculosis and Respiratory diseases. The
$7^{th}$ Na tionwide Survey for Tuberculosis. p 13, Seoul, 1996 - Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129
-
Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon-
$\gamma$ gene-disrupted mice. J Exp Med 1993;178:2243-7 - Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11:321-33
- Condos R, Rom WN, Schluger NW. Treatment of multidrug resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 1997;349:1513-5
-
Maeda J, Ueki N, Ohkawa T, Iwahashi N, Nakano T, Hada T, et al. Local production and localization of transforming growth factor-
$\beta$ in tuberculous pleurisy. Clin Exp Immunol 1993;92:32-8 - Kim MH, Kim SJ, Park YK, Kim SC, Lee SY, Kim YK, et al. The levels of interferon-gamma, interleukin-2 receptor, interleukin-6, interleukin-10 in malignant effusion, tuberculous effusion, parapneumonic effusion, and lung empyema. Tuberculosis and Respiratory Diseases 2000;49:568-75
-
Barnes PF, Mistry SD, Cooper CL, Pirmez C, Rea TH, Modlin RL. Compartmentalization of a
$CD^+$ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989;142:1114-9 - Ribera E, Espanol T, Martinez-Vasquez JM, Ocana I, Encabo G. Lymphocyte proliferation and gammainterferon production after in vitro stimulation withPPD. Difference between tuberculous and non tuberculous pleurisy in patients with positive tuberculih skin test. Chest 1990;97:1381-5
- Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ. Differential protective efficacy of DNA vaccines expressing secreted proteins of the Mycobacterium tuberculosis. Infect Immun 1999;67:1702-7
- Hunter SW, Brennan PJ. Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J Biol Chem 1990;265:9272-9
- Khoo KH, Dell A, Morris HR, Brennan PJ, Chatterjee D. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growingstrains of Mycobacterium. J Biol Chem 1995;270:12380-9
- Dahl KE, Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z. Selective induction of transforming growth factor beta in human monocytes by lipoarabinoman nan of Mycobacterium tuberculosis. Infect Immun 1996;64:399-405
- Stead WW, Einchenholz A, Stauss HK. Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculous. Am Rev Tuberc 1955;71:473-502
- Arruda S, Chalhoub M, Cardoso S, Barral-Netto M. Cell-mediated immune responses and cytotoxicity to mycobacterial antigens in patients with tuberculous pleurisy in Brazil. Acta Tropica 1998;71:1-15
- Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993;61:3482-9
- Schwander SK, Torres M, Sada E, Carranza C, Ramos E, Tary-Lehmann M, et al. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis 1998;178:1434-45
- Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. InfectImmun 1994;62:2536-44
- Wiker HG, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992;56:648-61
- Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000;97:13853-8
- Moreno C, Mehlert A, Lamb J. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin Exp Immunol 1988;74:206-10
- Chujor CS, Kuhn B, Schwerer B, Bernheimer H, Levis WR, Bevec D. Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkatby mycobacterial lipoarabinomannan antigen. Clin Exp Immunol 1992;87:398-403
- Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL. Local production of tumor necrosis factor and IFN-gamma in tuberculouspleuritis. J Immunol 1990;145:149-54